SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

PCVX VAX-31 phase III data expected by end of October

OPUS-1 phase III data for VAX-31 are expected to be released by end of October. The company says commercial and manufacturing infrastructure is in place, with pediatric and Group A strep programs advancing.

PCVX

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.